Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • Log out
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • Log out
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital

Kevin S. Akers, Katrin Mende, Heather C. Yun, Duane R. Hospenthal, Miriam L. Beckius, Xin Yu, Clinton K. Murray
Kevin S. Akers
San Antonio Military Medical Center, Fort Sam Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrin Mende
Infectious Disease Clinical Research Program, San Antonio, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather C. Yun
San Antonio Military Medical Center, Fort Sam Houston, TexasUniformed Services University of the Health Sciences, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duane R. Hospenthal
San Antonio Military Medical Center, Fort Sam Houston, TexasUniformed Services University of the Health Sciences, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam L. Beckius
San Antonio Military Medical Center, Fort Sam Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin Yu
San Antonio Military Medical Center, Fort Sam Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clinton K. Murray
San Antonio Military Medical Center, Fort Sam Houston, TexasUniformed Services University of the Health Sciences, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Clinton.Murray@amedd.army.mil
DOI: 10.1128/AAC.01405-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Infections with multidrug-resistant Acinetobacter baumannii-Acinetobacter calcoaceticus complex bacteria complicate the care of U.S. military personnel and civilians worldwide. One hundred thirty-three isolates from 89 patients at our facility during 2006 and 2007 were tested by disk diffusion, Etest, and broth microdilution for susceptibility to tetracycline, doxycycline, minocycline, and tigecycline. Minocycline was the most active in vitro, with 90% of the isolates tested susceptible. Susceptibilities varied significantly with the testing method. The acquired tetracycline resistance genes tetA, tetB, and tetA(39) were present in the isolates.

Multidrug-resistant Acinetobacter baumannii-Acinetobacter calcoaceticus complex bacteria cause infections in traumatic wounds in U.S. military personnel injured in Iraq and Afghanistan (9). A previous study of isolates recovered at our facility during 2003 to 2005 found these isolates to be highly susceptible to minocycline (6), and our clinical experience with minocycline for the treatment of these infections has been favorable (5). The possibility of increasing resistance to minocycline is of concern, as it would further restrict therapeutic options for multidrug-resistant isolates and may necessitate the use of agents with a greater potential for toxicity, such as colistin. Tigecycline has been proposed as a therapeutic option for multidrug-resistant A. baumannii-A. calcoaceticus complex infections (Tygacil package insert, Wyeth Pharmaceuticals, 2005), but its in vitro activity against isolates of military origin is uncertain.

The antibiogram for tetracycline, doxycycline, minocycline, and tigecycline was determined by using 133 clinical isolates from blood and wound infections of 89 patients admitted to our facility in 2006 and 2007. Serial isolates were included only when separated by at least 72 h. Susceptibilities to each antimicrobial were determined from a single measurement by disk diffusion (Becton Dickinson, Sparks, MD), Etest (AB Biodisk, Solna, Sweden), and broth microdilution by the methods of the Clinical and Laboratory Standards Institute (CLSI) (3). Discordant results were tabulated as very major errors (reported susceptible when resistant), major errors (reported resistant when susceptible), or minor errors (reported intermediate when resistant or susceptible or vice versa). CLSI interpretive criteria were used (4), except for tigecycline, for which no interpretive criteria are available.

Clonal relationships were assessed by pulsed-field gel electrophoresis (PFGE) with ApaI digestion (Centers for Disease Control and Prevention PulseNet protocols; http://www.cdc.gov/PULSENET/protocols.htm [accessed 25 July 2007]), with modifications for Acinetobacter. Strains were considered to be related if their Dice coefficient was ≥85% (Bionumerics; Applied Maths Inc., Austin, TX). The 89 single-patient isolates were confirmed to be members of the A. baumannii-A. calcoaceticus complex by amplification of blaOXA-51-like β-lactamase genes and by amplified ribosomal DNA restriction analysis (ARDRA) with the restriction enzymes AluI, HinfI, HhaI, RsaI, MboI, and MspI (12, 13).

The presence of tetracycline resistance genes in 89 single-patient isolates was determined by PCR amplification for the tetA, tetB, tetH, tetL, tetM, tetA(39), and tetA(41) genes with previously published primer sequences by previously described methods (1, 8, 11). Data were analyzed according to susceptibility phenotype, PFGE type, and Acinetobacter species as determined by ARDRA.

Consistent with our clinical experience and prior laboratory observations, minocycline had the highest in vitro activity, reflected in the MICs for 50 and 90% of the strains tested (MIC50 and MIC90, respectively) and the percentage of isolates susceptible according to the broth microdilution method (Table 1). The in vitro activities of tetracycline and doxycycline were low. The modal MIC of minocycline was more favorable than that of tigecycline.

The accuracy of the disk diffusion and Etest methods was evaluated by comparing the results of 133 isolates tested by these methods to the reference method of broth microdilution (Table 2). Minocycline susceptibility varied widely by testing method, from 36.8% by disk diffusion to 88.7% by broth microdilution. No very major errors were observed. Etest committed fewer major errors than disk diffusion for doxycycline, while the methods were equivalent for minocycline. Etest committed fewer minor errors than disk diffusion for tetracycline and minocycline. There was no predominating type of minor error for either testing method (data not shown).

The accuracy of disk diffusion testing for determining minocycline susceptibility was poor. By this method, 51% of the isolates in this study would have been incorrectly reported as nonsusceptible to minocycline. This likely occurred due to clustering of the inhibitory zone diameter at or near the susceptibility breakpoint for minocycline in many isolates. Utilizing the Etest would have incorrectly reported 18% of the isolates as nonsusceptible to minocycline, a considerable improvement over disk diffusion but still exceeding the allowable limits of the CLSI (2). High disk diffusion error rates for Acinetobacter have been previously reported for tetracycline (10) and tigecycline (7).

We observed 24 distinct PFGE types among the 89 single-patient isolates. Approximately two-thirds of the isolates were represented by four PFGE types (Table 3), composed of A. baumannii, A. calcoaceticus, or isolates that were indistinguishable between these by ARDRA (considered to be A. baumannii-A. calcoaceticus complex isolates). All isolates carried the blaOXA-51-like β-lactamase gene. Three PFGE types comprising 61% of the isolates were associated with a minocycline MIC90 within the susceptible range. Among these three PFGE types, the percentages of isolates susceptible to tetracycline, doxycycline, and minocycline were 0, 18.5, and 100%, respectively.

The tetracycline resistance determinants tetH, tetL, tetM, and tetA(41) were not found in any isolates. The frequencies of tetA, tetB, and tetA(39) increased with advancing resistance phenotype but were less common in the most resistant phenotype. tetA was predominantly found in PFGE type 2 (A. baumannii). tetB was found in all species and was more common in the less frequent PFGE types. tetA(39) was abundant in PFGE type 1 (A. baumannii-A. calcoaceticus complex) isolates retaining susceptibility to minocycline. tetB was found in isolates resistant to all of the agents tested, as well as in isolates retaining susceptibility to minocycline.

Multidrug-resistant A. baumannii-A. calcoaceticus complex bacteria remain an important cause of infection around the world. Minocycline is active against isolates of military origin, even when susceptibility to other tetracyclines and tigecycline has been lost. Determining minocycline susceptibility is hampered by important differences in accuracy between susceptibility testing methods, with the disk diffusion method significantly underestimating the proportion of susceptible isolates. Thus, in cases of infection with multidrug-resistant A. baumannii-A. calcoaceticus complex bacteria where minocycline therapy is desirable, it may be prudent to perform broth microdilution testing to obtain the most accurate susceptibility determination.

View this table:
  • View inline
  • View popup
TABLE 1.

Broth microdilution susceptibilities and MIC distribution from 89 single-patient A. baumannii-A. calcoaceticus complex isolates

View this table:
  • View inline
  • View popup
TABLE 2.

Rates of susceptibility testing errors among 133 clinical isolates by antimicrobial agent and testing method

View this table:
  • View inline
  • View popup
TABLE 3.

MIC90s and tetracycline resistance gene distribution by phenotype, PFGE type, and species among 89 single-patient A. baumannii-A. calcoaceticus complex isolates

ACKNOWLEDGMENTS

The opinions or assertions contained herein are our private views and are not to be construed as official or reflecting the views of the Department of the Army, the Department of the Air Force, the Department of Defense, or the U.S. Government.

FOOTNOTES

    • Received 20 October 2008.
    • Returned for modification 1 December 2008.
    • Accepted 14 March 2009.
  • ↵▿ Published ahead of print on 23 March 2009.

  • American Society for Microbiology

REFERENCES

  1. ↵
    Agersø, Y., and A. Petersen. 2007. The tetracycline resistance determinant Tet 39 and the sulphonamide resistance gene sulII are common among resistant Acinetobacter spp. isolated from integrated fish farms in Thailand. J. Antimicrob. Chemother. 59:23-27.
    OpenUrlCrossRefPubMed
  2. ↵
    Clinical and Laboratory Standards Institute. 2008. Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents—approved guideline, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
  3. ↵
    Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests: approved standard (M2-A9), 9th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
  4. ↵
    Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement (M100-S17). Clinical and Laboratory Standards Institute, Wayne, PA.
  5. ↵
    Griffith, M. E., H. C. Yun, L. L. Horvath, and C. K. Murray. 2008. Minocyline therapy for traumatic wound infections caused by the multidrug-resistant Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Infect. Dis. Clin. Pract. 16:16-19.
    OpenUrlCrossRef
  6. ↵
    Hawley, J. S., C. K. Murray, M. E. Griffith, M. L. McElmeel, L. C. Fulcher, D. R. Hospenthal, and J. H. Jorgensen. 2007. Susceptibility of Acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob. Agents Chemother. 51:376-378.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Jones, R. N., M. J. Ferraro, L. B. Reller, P. C. Schreckenberger, J. M. Swenson, and H. S. Sader. 2007. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J. Clin. Microbiol. 45:227-230.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Miranda, C. D., C. Kehrenberg, C. Ulep, S. Schwarz, and M. C. Roberts. 2003. Diversity of tetracycline resistance genes in bacteria from Chilean salmon farms. Antimicrob. Agents Chemother. 47:883-888.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Scott, P., G. Deye, A. Srinivasan, C. Murray, K. Moran, E. Hulten, J. Fishbain, D. Craft, S. Riddell, L. Lindler, J. Mancuso, E. Milstrey, C. T. Bautista, J. Patel, A. Ewell, T. Hamilton, C. Gaddy, M. Tenney, G. Christopher, K. Petersen, T. Endy, and B. Petruccelli. 2007. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin. Infect. Dis. 44:1577-1584.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    Swenson, J. M., G. E. Killgore, and F. C. Tenover. 2004. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods. J. Clin. Microbiol. 42:5102-5108.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Thompson, S. A., E. V. Maani, A. H. Lindell, C. J. King, and J. V. McArthur. 2007. Novel tetracycline resistance determinant isolated from an environmental strain of Serratia marcescens. Appl. Environ. Microbiol. 73:2199-2206.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Turton, J. F., N. Woodford, J. Glover, S. Yarde, M. E. Kaufmann, and T. L. Pitt. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Vaneechoutte, M., L. Dijkshoorn, I. Tjernberg, A. Elaichouni, P. de Vos, G. Claeys, and G. Verschraegen. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33:11-15.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital
Kevin S. Akers, Katrin Mende, Heather C. Yun, Duane R. Hospenthal, Miriam L. Beckius, Xin Yu, Clinton K. Murray
Antimicrobial Agents and Chemotherapy May 2009, 53 (6) 2693-2695; DOI: 10.1128/AAC.01405-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
Share
Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital
Kevin S. Akers, Katrin Mende, Heather C. Yun, Duane R. Hospenthal, Miriam L. Beckius, Xin Yu, Clinton K. Murray
Antimicrobial Agents and Chemotherapy May 2009, 53 (6) 2693-2695; DOI: 10.1128/AAC.01405-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596